Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland

Thomas R. Einarson, Hanna Pudas, Roman Zilbershtein, R. Jensen, Colin Vicente, Charles Piwko, M. Hemels

Journal of Medical Economics · 2013 · 15 citations · 40 references

DOIFull text

Open access

Abstract

In Finland, PP-LAI dominated the other LAIs as it was associated with a lower cost and better clinical outcomes.

References

40